Search for: "RANBAXY LABORATORIES LTD." Results 21 - 40 of 70
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 May 2011, 11:59 pm
Reddy's Laboratories that will enable a generic version of Effexor XR to enter the market on June 1, 2011. [read post]
3 Mar 2013, 12:06 pm by Rajiv Kr. Choudhry
Patil 337/DELNP/2003 LANXESS DEUTSCHLAND GMBH Granted Dr.Rajesh Dixit 4069/DELNP/2006 RANBAXY LABORATORIES LIMITED Withdrawn Hardev Karar 106/DELNP/2008 ALFA WASSERMANN S. [read post]
5 Dec 2011, 10:00 am by Lucas A. Ferrara, Esq.
 Ranbaxy Laboratories Ltd. has gained approval to make generic atorvastatin calcium tablets in 10 milligram, 20 mg, 40 mg, and 80 mg strengths. [read post]
24 May 2021, 7:34 am by Deb Givens
  A federal judge has approved multiple classes in litigation accusing Indian generic drugmaker Ranbaxy Laboratories Ltd of delaying the launch of generic drugs by submitting false applications to U.S. regulators. [read post]
20 Oct 2009, 3:06 pm
In January 2008, Ranbaxy Laboratories Ltd. [read post]
6 Oct 2010, 4:31 pm by Jason Rantanen
  With respect to the jurisdictional issue, the court focused on two cases: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
30 Jun 2013, 1:12 pm by Sai Vinod
The petition is more or less similar to Super Cassettes Industries Ltd. [read post]
10 Oct 2013, 8:42 am by Jonathan Tycko
Ranbaxy USA Inc. ($500 Million) Ranbaxy USA Inc., a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited, agreed to pay a total of $500 million to settle criminal and civil allegations filed against the company. [read post]
3 Nov 2006, 6:25 am
Chemicals & Pharmaceuticals Ltd., Mumbai, India (varun.chhonkar[at]jbcpl.com). [read post]
18 Feb 2014, 12:43 pm by Dennis Crouch
Ranbaxy Laboratories Ltd., 457 F.3d 1284 (Fed. [read post]
6 Oct 2010, 11:43 pm by FDABlog HPM
  Teva appealed the decision arguing that the case should proceed, and the Federal Circuit agreed applying a 2008 decision in Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
17 Nov 2010, 1:48 am by Kelly
Highlights this week included: Efexor (Venlafaxine) – Australia: Federal Court blocks generic Efexor-XR: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd (Patentology) (BAZPAT) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
18 Sep 2013, 1:51 am by Kevin LaCroix
Food and Drug Administration, as part of its effort to block exports to the United States from the Indian drug manufacturing plant of Indian-based Ranbaxy Laboratories Ltd due to alleged safety violations, the U.S. agency has required the company “to hire a third-party expert to inspect the Mohali facility and certify to the FDA that any violations have been addressed and that the company has processes in place to ensure continuing compliance. [read post]